Digital Pathology Market - Global Forecast 2025-2032

Digital pathology is revolutionizing the healthcare and life sciences sectors, transforming diagnostic accuracy, research processes, and enterprise-wide clinical workflows through a data-driven approach. Senior decision-makers are increasingly evaluating digital solutions to remain competitive and improve operational outcomes.

Market Snapshot: Digital Pathology Market

The Digital Pathology Market expanded from USD 1.25 billion in 2024 to USD 1.44 billion in 2025 and is forecasted to continue its robust trajectory with a CAGR of 15.90%, reaching USD 4.09 billion by 2032.

Scope & Segmentation

This report provides a comprehensive assessment designed for senior leadership to benchmark solutions, map technology trends, and build effective strategies across the digital pathology market. Key market segmentation covers:

• Type: Human Pathology and Veterinary Pathology, addressing diagnostic and research needs in both healthcare delivery and animal science to enable wide-ranging applications.
• Product: Displays such as Consumer off the Shelf, Medical Grade, and Professional Grade; Scanners including Brightfield and Fluorescence types; and Storage Systems all enhance reliability in image capture and data management.
• Services: Consulting & Implementation, Maintenance & Support, and Training Services are critical for achieving maximum technological impact, securing uptime, and driving skilled adoption across organizations.
• Software: Image Management Systems (IMS), Laboratory Information Systems (LIS), and Picture Archiving and Communication Systems (PACS) drive digital workflow automation and facilitate knowledge scaling across labs and institutions.
• Application: Biomarker Discovery, Disease Diagnosis—including Infectious Diseases, Neurology, Oncology—Drug Discovery & Development, Telepathology, Toxicology Studies, and Training & Education, all represent essential drivers for advancing precision medicine and research translation.
• End User: Academic & Research Institutes, Contract Research Organizations, Government & Regulatory Bodies, Hospitals & Diagnostic Labs, and Pharmaceutical & Biotechnology Companies, illustrating broad cross-organizational adoption.
• Regions: Americas—with detailed inclusion of the United States, Canada, Mexico, Brazil, Argentina, Chile, Colombia, Peru—Europe, Middle East & Africa (with markets in Western and Eastern Europe, the Gulf, and select African countries), and Asia-Pacific (comprising China, India, Japan, Australia, South Korea, Indonesia, Thailand, Malaysia, Singapore, Taiwan), demonstrating broad geographic expansion and diverse regulatory environments.
• Key Companies: F. Hoffmann-La Roche Ltd., FUJIFILM Holdings Corporation, 3DHISTECH Ltd., Aiforia Technologies PLC, Charles River Laboratories, Corista LLC, Danaher Corporation, Deep Bio Inc., Epredia, General Electric Company, Hamamatsu Photonics K.K., Huron Digital Pathology, Indica Labs, Koninklijke Philips N.V., Laboratory Corporation of America Holdings, Mikroscan Technologies, Inc., Motic, Nikon Corporation, OptraSCAN Inc., Pathcore Inc., PathPresenter Corporation, PerkinElmer, Inc., Proscia, Inc., Quest Diagnostics Incorporated, Sectra AB, Visiopharm A/S, Xybion Digital Inc., Olympus Corporation, Akoya Biosciences.

Key Takeaways for Senior Decision-Makers

• Digital pathology is growing from niche research use toward enabling diagnostics and large-scale translational research, fostering organizational efficiencies and supporting enterprise strategy alignment.
• Investments in fast scanners, advanced software analytics, and robust data platforms facilitate seamless integration across clinical and research settings while improving decision accuracy.
• Regulatory landscapes and evolving reimbursement frameworks are prompting adoption, yet require thorough clinical validation before full deployment, highlighting risk management needs for large-scale projects.
• Adoption of hybrid infrastructure models, combining on-premise controls with cloud-based analytics, helps organizations balance compliance, scalability, and streamlined performance.
• Procurement strategies increasingly adjust for dynamic tariff policies and complex global supply chains, supporting resilience and cost efficiency through flexible sourcing and contract management.
• Embracing interoperability and open standards ensures collaboration across vendors, supporting federated research and broadening the potential for global clinical networks within digital pathology.

Tariff Impact: Navigating Procurement Challenges

Shifting tariff and trade rules in the digital pathology sector are reshaping equipment pricing and extending supply chain lead times. Senior executives are mitigating these procurement challenges by exploring alternative suppliers, renegotiating contracts for better terms, and opting for modular system upgrades over comprehensive replacements. These measures not only stabilize operational costs but also enable consistent innovation and maintain workflow continuity despite regulatory volatility.

Methodology & Data Sources

The report integrates insights from interviews with laboratory directors, pathologists, R&D leads, and procurement professionals, alongside robust secondary research. This methodology grounds analysis in current industry practices and ensures that recommendations are operationally relevant.

Why This Report Matters

• Offers clear assessments of digital technology vendors and solutions, supporting procurement aligned with evolving regulatory standards and unique business goals.
• Guides leaders in designing scalable digital pathology frameworks, enabling smooth transitions from pilot projects to enterprise-wide adoption.
• Clarifies risk factors from tariffs and system integration, equipping executives to adapt procurement policies and support sustainable, compliant growth.

Conclusion

Digital pathology is enabling higher quality and operational efficiency for organizations. Proactive adaptation to regulatory, technological, and supply chain dynamics will position leaders for lasting value in a rapidly evolving market landscape.

Additional Product Information:

• Purchase of this report includes 1 year online access with quarterly updates.
• This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.